SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-19-073088
Filing Date
2019-12-16
Accepted
2019-12-16 17:11:32
Documents
4
Group Members
KOH, BONGSHAH, NIMISHVENROCK HEALTHCARE CAPITAL PARTNERS III, L.P.VHCP CO-INVESTMENT HOLDINGS II, LLCVHCP CO-INVESTMENT HOLDINGS III, LLCVHCP MANAGEMENT II, LLCVHCP MANAGEMENT III, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G a19-26346_1sc13g.htm SC 13G 318170
2 EX-99.A a19-26346_1ex99da.htm EX-99.A 31722
3 EX-99.B a19-26346_1ex99db.htm EX-99.B 7238
4 EX-99.C a19-26346_1ex99dc.htm EX-99.C 7230
  Complete submission text file 0001104659-19-073088.txt   366250
Mailing Address 880 3RD AVENUE, 12TH FLOOR NEW YORK NY 10022
Business Address 880 3RD AVENUE, 12TH FLOOR NEW YORK NY 10022 646 876 3459
RELMADA THERAPEUTICS, INC. (Subject) CIK: 0001553643 (see all company filings)

IRS No.: 455401931 | State of Incorp.: NV | Fiscal Year End: 0630
Type: SC 13G | Act: 34 | File No.: 005-88207 | Film No.: 191288010
SIC: 2834 Pharmaceutical Preparations

Mailing Address 7 BRYANT PARK 23RD FLOOR NEW YORK NY 10018
Business Address 7 BRYANT PARK 23RD FLOOR NEW YORK NY 10018 650 475 3734
Venrock Healthcare Capital Partners II, L.P. (Filed by) CIK: 0001602264 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G